Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Bile Duct Neoplasms × durvalumab × Clear all

Phase

Status

Recruiting 2 Active not recruiting 2 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 7 Small Cell Lung Carcinoma 4 Carcinoma, Hepatocellular 4 Lung Neoplasms 2 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Urinary Bladder Neoplasms 1 Respiratory Tract Neoplasms 1 Rare Tumour 1 Pathologic Complete Response 1 Pancoast Syndrome 1 Ovarian Neoplasms 1 Locally Advanced Rectal Carcinoma 1 Liver Neoplasms 1 Gallbladder Neoplasms 1 Gallbladder Cancer Unresectable 1 Bile Duct Neoplasms 1 Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 2 Cisplatin 2 tislelizumab 1 durvalumab 1 Stents 1 Radiosurgery 1 Oxaliplatin 1 Injections, Subcutaneous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06274879 2025-01-09

Ablatio

Insel Gruppe AG, University Hospital Bern

Phase 2 Not yet recruiting

Gastrointestinal

Bile Duct Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡